|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
ZA836080B
(en)
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US5106619A
(en)
|
1983-12-20 |
1992-04-21 |
Diamond Scientific Co. |
Preparation of inactivated viral vaccines
|
|
US4693981A
(en)
|
1983-12-20 |
1987-09-15 |
Advanced Genetics Research Institute |
Preparation of inactivated viral vaccines
|
|
FR2583429B1
(fr)
|
1985-06-18 |
1989-11-03 |
Transgene Sa |
Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
ES2087997T3
(es)
|
1990-01-12 |
1996-08-01 |
Cell Genesys Inc |
Generacion de anticuerpos xenogenicos.
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6034298A
(en)
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
|
US5612487A
(en)
|
1991-08-26 |
1997-03-18 |
Edible Vaccines, Inc. |
Anti-viral vaccines expressed in plants
|
|
US5484719A
(en)
|
1991-08-26 |
1996-01-16 |
Edible Vaccines, Inc. |
Vaccines produced and administered through edible plants
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
AU6014094A
(en)
|
1992-12-02 |
1994-06-22 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
WO1994016109A1
(en)
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
EP1394259A3
(en)
|
1994-07-18 |
2004-04-14 |
Karl-Klaus Prof. Dr. Conzelmann |
Recombinant infectious non-segmented negative strand RNA virus
|
|
EP0789774A2
(en)
|
1994-10-03 |
1997-08-20 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
|
|
EP0822830B1
(en)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Human anti-IL-8 antibodies, derived from immunized xenomice
|
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
ATE181112T1
(de)
|
1995-08-09 |
1999-06-15 |
Schweiz Serum & Impfinst |
Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
|
|
US6264957B1
(en)
|
1995-09-27 |
2001-07-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Product of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
JP2820106B2
(ja)
|
1996-02-29 |
1998-11-05 |
日本電気株式会社 |
トラヒックシェーパ装置
|
|
US6942861B2
(en)
|
1996-04-19 |
2005-09-13 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
|
|
AU722327B2
(en)
|
1996-04-19 |
2000-07-27 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
|
|
ATE451451T1
(de)
|
1996-07-15 |
2009-12-15 |
Us Gov Health & Human Serv |
Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen
|
|
US20050032211A1
(en)
|
1996-09-26 |
2005-02-10 |
Metabogal Ltd. |
Cell/tissue culturing device, system and method
|
|
IL155588A0
(en)
|
2003-04-27 |
2003-11-23 |
Metabogal Ltd |
Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
|
|
KR20000048628A
(ko)
|
1996-09-27 |
2000-07-25 |
윌리암 에이취 캘넌, 에곤 이 버그 |
모노네가비랄레스 목의 바이러스에서 감쇠를 책임지는 3' 게놈프로모터 영역 및 폴리머라제 유전자 돌연변이
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP2305027B1
(en)
|
1996-12-03 |
2014-07-02 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
|
US5891705A
(en)
|
1997-04-08 |
1999-04-06 |
Pentose Pharmaceuticals, Inc. |
Method for inactivating a virus
|
|
SI0970126T1
(en)
|
1997-04-14 |
2001-08-31 |
Micromet Ag |
Novel method for the production of antihuman antigen receptors and uses thereof
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
CN1250725C
(zh)
|
1997-05-23 |
2006-04-12 |
美国政府健康及人类服务部 |
从克隆的核苷酸序列制备减毒副流感病毒疫苗的方法
|
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
JP4434478B2
(ja)
|
1997-07-11 |
2010-03-17 |
イエール ユニバーシティー |
リエンジニアリングされた外被を有するラブドウイルス
|
|
WO1999015672A1
(en)
|
1997-09-19 |
1999-04-01 |
American Cyanamid Company |
Attenuated respiratory syncytial viruses
|
|
DK2316923T3
(en)
|
1998-06-12 |
2018-01-08 |
Icahn School Med Mount Sinai |
Attenuated influenza viruses with altered interferon antagonist activity for use as vaccines and drugs
|
|
EP1098961B1
(en)
|
1998-06-12 |
2008-01-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Interferon inducing genetically engineered attenuated viruses
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
AU776855B2
(en)
|
1998-12-23 |
2004-09-23 |
Boyce Thompson Institute For Plant Research Inc. |
Expression of immunogenic hepatitis B surface antigens in transgenic plants
|
|
AT407958B
(de)
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
|
AU4134000A
(en)
|
1999-04-29 |
2000-11-17 |
Syngenta Limited |
Herbicide resistant plants
|
|
EP1194580B2
(en)
|
1999-07-14 |
2010-08-25 |
Mount Sinai School of Medicine of New York University |
In vitro reconstitution of segmented negative-strand rna viruses
|
|
AR025750A1
(es)
|
1999-09-24 |
2002-12-11 |
Smithkline Beecham Biolog |
Vacunas
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
US6770799B2
(en)
|
2000-03-17 |
2004-08-03 |
Thompson Boyce Plant Res |
Expression of recombinant human acetylcholinesterase in transgenic plants
|
|
CN100489107C
(zh)
|
2000-04-28 |
2009-05-20 |
圣朱德儿童研究医院 |
用于产生感染性流感病毒的dna转染系统
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
EP3009507B1
(en)
|
2002-02-13 |
2020-06-24 |
Wisconsin Alumini Research Foundation |
Signal for packaging of influenza virus vectors
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
WO2004067553A2
(en)
|
2003-01-29 |
2004-08-12 |
The Research Foundation Of The State University Of New York |
Tolerance-induced targeted antibody production
|
|
JP4675317B2
(ja)
|
2003-01-30 |
2011-04-20 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
アジュバント化インフルエンザワクチン
|
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
JP4368594B2
(ja)
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
US7951557B2
(en)
|
2003-04-27 |
2011-05-31 |
Protalix Ltd. |
Human lysosomal proteins from plant cell culture
|
|
CN100393870C
(zh)
|
2003-05-05 |
2008-06-11 |
波依斯汤普森植物研究所 |
用于制备免疫保护性组合物的载体和来源于转基因植物的细胞
|
|
CA2525698C
(en)
|
2003-05-26 |
2013-10-22 |
Toray Industries, Inc. |
A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
DK2261376T3
(da)
|
2003-11-04 |
2013-10-07 |
Univ Tulane |
Fremgangsmåde til hindring af virus:celle-fusion ved hæmning af funktionen af fusionsinitieringsregionen i RNA vira med klasse I membranfusogene indhyldningsproteiner
|
|
EP1766059B1
(en)
|
2004-05-25 |
2012-07-11 |
MedImmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
JP2008515454A
(ja)
|
2004-10-13 |
2008-05-15 |
プロタリクス リミテッド |
植物細胞培養における抗体製造のシステムおよび方法
|
|
CA2598884A1
(en)
|
2005-02-24 |
2006-10-05 |
University Of Massachusetts |
Influenza nucleic acids, polypeptides, and uses thereof
|
|
EP1885186B1
(en)
|
2005-06-01 |
2015-09-02 |
California Institute Of Technology |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
US7951384B2
(en)
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
|
US20070064857A1
(en)
|
2005-08-19 |
2007-03-22 |
Winterberg Friedwardt M |
Thermonuclear plasma confinement with thermomagnetic currents generated by nuclear reactions from fusion neutrons
|
|
US8098789B2
(en)
|
2005-09-09 |
2012-01-17 |
Wisconsin Alumni Research Foundation |
Systems and methods for the cyclotron production of iodine-124
|
|
US8662363B2
(en)
|
2005-09-27 |
2014-03-04 |
Dennis Williams |
Golf car accessory
|
|
PL1951299T3
(pl)
|
2005-11-04 |
2012-07-31 |
Novartis Ag |
Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
|
|
EP2251034B1
(en)
|
2005-12-02 |
2018-02-14 |
Icahn School of Medicine at Mount Sinai |
Chimeric newcastle disease viruses presenting non-native surface proteins and uses thereof
|
|
ES2385842T3
(es)
|
2005-12-06 |
2012-08-01 |
Yeda Research And Development Co., Ltd. |
Vacuna mejorada contra la gripe
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
JP2009526526A
(ja)
|
2006-02-13 |
2009-07-23 |
フラウンホーファー ユーエスエー， インコーポレイテッド |
インフルエンザ抗原、ワクチン組成物、および関連する方法
|
|
US20070207171A1
(en)
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
|
EP3011969A1
(en)
|
2006-03-07 |
2016-04-27 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
US8063063B2
(en)
|
2006-03-23 |
2011-11-22 |
Novartis Ag |
Immunopotentiating compounds
|
|
WO2007109813A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
|
JP2009534303A
(ja)
|
2006-03-24 |
2009-09-24 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
冷蔵しないインフルエンザワクチンの保存
|
|
US20070262178A1
(en)
|
2006-05-12 |
2007-11-15 |
Ultradent Products, Inc. |
Syringe delivery tip including an enlarged flocked wing element adjacent a distal delivery end
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
WO2007134327A2
(en)
|
2006-05-15 |
2007-11-22 |
Sea Lane Biotechnologies, Llc. |
Neutralizing antibodies to influenza viruses
|
|
WO2008054540A2
(en)
|
2006-05-18 |
2008-05-08 |
Pharmexa Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
WO2008005777A2
(en)
|
2006-06-30 |
2008-01-10 |
Novavax, Inc. |
Methods of enhancing protein incorporation into virus like particles
|
|
AU2007275010B2
(en)
|
2006-07-21 |
2013-06-20 |
California Institute Of Technology |
Targeted gene delivery for dendritic cell vaccination
|
|
CA2663388C
(en)
|
2006-09-07 |
2017-01-17 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
|
|
WO2008032219A2
(en)
|
2006-09-11 |
2008-03-20 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
|
US20080075998A1
(en)
|
2006-09-22 |
2008-03-27 |
Tatsumi Ishihara |
Electrolyte membrane for electrochemical cell and a method of producing the same
|
|
US20080085876A1
(en)
|
2006-10-05 |
2008-04-10 |
Schwartz David L |
Insect sting treatment
|
|
CN101607995B
(zh)
|
2007-06-15 |
2013-05-01 |
厦门大学 |
特异性结合h5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途
|
|
EP2014279A1
(en)
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
HRP20120790T1
(hr)
|
2007-06-27 |
2013-01-31 |
Novartis Ag |
Cjepiva protiv influence sa niskom koliäśinom aditiva
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
US20090092635A1
(en)
|
2007-08-17 |
2009-04-09 |
Wyeth |
Heterologous prime-boost immunization regimen
|
|
EP2200639B1
(en)
|
2007-09-24 |
2016-03-30 |
Government of the USA, as Represented by the Secretary, Department of Health and Human Services |
Immunostimulatory combinations of tlr3 ligands with tlr2 and tlr9 agonists and methods of use
|
|
FR2921387B1
(fr)
*
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
PT2610345E
(pt)
|
2007-11-27 |
2016-01-11 |
Medicago Inc |
Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
|
|
MX2010006148A
(es)
|
2007-12-06 |
2011-02-23 |
Dana Farber Cancer Inst Inc |
Anti-cuerpos contra el virus de la influenza y metodos de uso de los mismos.
|
|
WO2009092038A1
(en)
|
2008-01-16 |
2009-07-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Influenza dna vaccination and methods of use thereof
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
WO2009121004A2
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
ES2524553T3
(es)
|
2008-06-17 |
2014-12-10 |
Apogenix Gmbh |
Receptores multiméricos de TNF
|
|
EP2294202B1
(en)
|
2008-07-08 |
2015-05-20 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
WO2010036948A2
(en)
|
2008-09-26 |
2010-04-01 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Dna prime/inactivated vaccine boost immunization to influenza virus
|
|
CA2787099A1
(en)
|
2009-03-30 |
2010-10-14 |
Anice C. Lowen |
Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
|
|
WO2010130636A1
(en)
|
2009-05-11 |
2010-11-18 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
AU2010254136B2
(en)
|
2009-05-26 |
2016-09-29 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
JP5871796B2
(ja)
|
2009-06-24 |
2016-03-01 |
メディカゴ インコーポレイテッド |
ヘマグルチニンを含むキメラインフルエンザウイルス様粒子
|
|
CA2805505C
(en)
|
2009-07-30 |
2021-08-03 |
Mount Sinai School Of Medecine |
Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
WO2011044152A1
(en)
|
2009-10-05 |
2011-04-14 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer |
Protection against pandemic and seasonal strains of influenza
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
US9701723B2
(en)
|
2010-02-18 |
2017-07-11 |
Icahn School Of Medicine At Mount Sinai |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
US9573991B2
(en)
|
2010-03-08 |
2017-02-21 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
|
|
CN102939103A
(zh)
|
2010-03-30 |
2013-02-20 |
西奈山医学院 |
流感病毒疫苗及其应用
|
|
EP2596017B1
(en)
|
2010-07-22 |
2019-04-03 |
John W. Schrader |
Cross-protective antibody against influenza viral infection
|
|
KR20140068205A
(ko)
|
2011-09-20 |
2014-06-05 |
마운트 시나이 스쿨 오브 메디슨 |
인플루엔자 바이러스 백신 및 이의 용도
|
|
MY170927A
(en)
|
2011-11-28 |
2019-09-19 |
Janssen Vaccines & Prevention Bv |
Influenza virus vaccines and uses thereof
|
|
CA2894506C
(en)
|
2012-12-11 |
2021-08-10 |
Vib Vzw |
Anti-influenza antibody
|
|
KR20150104117A
(ko)
|
2012-12-18 |
2015-09-14 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
인플루엔자 바이러스 백신 및 그의 용도
|
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
CN105209071A
(zh)
|
2013-03-14 |
2015-12-30 |
抗非特公司 |
用于提高疗效的基于鼻内递送中和抗体的组合物和方法
|
|
EA035375B1
(ru)
|
2014-07-10 |
2020-06-03 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцины против вируса гриппа и их применения
|
|
CN106661091B
(zh)
|
2014-07-10 |
2020-10-30 |
扬森疫苗与预防公司 |
流行性感冒病毒疫苗及其用途
|